Futura Medical beats forecasts as Eroxon heads for 20-country rollout
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has reported full-year results ahead of market expectations, as demand for its flagship product, Eroxon, gathers pace across international markets. The company now expects the topical erectile dysfunction treatment …